Edition:
United States

Gemphire Therapeutics Inc (GEMP.OQ)

GEMP.OQ on NASDAQ Stock Exchange Global Market

1.13USD
23 Jan 2019
Change (% chg)

$0.05 (+4.63%)
Prev Close
$1.08
Open
$1.13
Day's High
$1.13
Day's Low
$1.13
Volume
1,216
Avg. Vol
37,663
52-wk High
$11.41
52-wk Low
$0.57

Chart for

About

Gemphire Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the development and commercialization of therapeutics to treat cardiovascular and metabolic diseases. It is developing its product candidate, gemcabene (CI-1027), which is a once-daily, oral therapy for patients who are unable to... (more)

Overall

Beta: --
Market Cap(Mil.): $17.40
Shares Outstanding(Mil.): 14.27
Dividend: --
Yield (%): --

Financials

  GEMP.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -2.11 -- --
ROI: -143.81 0.60 13.80
ROE: -256.97 -2.18 15.29

Earnings vs. Estimates